SYN is a Pharmaceutical company based in Athens, focused on medicines- nutritions for chronic, life-threatening and rare diseases, providing one stop shop services for SE European countries for diagnosis, treatment and therapy.
The personnel and the owners have multinational experience and long-term relationships with the health stakeholders and profound capabilities ,with proven efficacy from CxO positions for more than 20 years in SE Europe countries.

Milestones

2015

Distribution agreement with Fresenius-kabi enteral nutrition

2015

Creation of PharmaVision Europe for expansion in South Balkans countries (Bulgaria ,Albania ,Kosovo) and Cyprus

2015

Launching Lipiodol orphan liver embolization

2015

relaunching Guerbet’s contrast media portofolio in Greece and Cyprus

4>

2014

Submission cyclotron business plan

2014

Initiation of imaging-diagnosis Unit

Mission

Provide patients with high quality, innovative, life changing medicines for diagnosis, treatment and therapy

Vision

SYN shall be the preferred partner, well known, respectful and distinct pharmaceutical company proving high quality medications and innovative products

Values

SYN invests in emotional intelligence, promoting teamwork, highly workgroups and a unique altruistic chemistry
SYN embraces innovation, continuous learning and challenging changes
SYN is recognized by everyone as a company that fulfills its responsibilities contributes towards the society